These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 16380106
1. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Ajith TA, Harikumar KB, Thasna H, Sabu MC, Babitha NV. Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106 [Abstract] [Full Text] [Related]
2. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice. Ajith TA, Anu V, Riji T. J Exp Ther Oncol; 2008 Apr; 7(4):291-8. PubMed ID: 19227009 [Abstract] [Full Text] [Related]
5. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC. Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [Abstract] [Full Text] [Related]
6. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H. Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488 [Abstract] [Full Text] [Related]
7. Antitumor and antioxidant activity of Polyalthia longifolia stem bark ethanol extract. Manjula SN, Kenganora M, Parihar VK, Kumar S, Nayak PG, Kumar N, Ranganath Pai KS, Rao CM. Pharm Biol; 2010 Jun; 48(6):690-6. PubMed ID: 20645743 [Abstract] [Full Text] [Related]
9. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ. Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904 [Abstract] [Full Text] [Related]
10. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Kah J, Wüstenberg A, Keller AD, Sirma H, Montalbano R, Ocker M, Volz T, Dandri M, Tiegs G, Sass G. Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979 [Abstract] [Full Text] [Related]
14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA. Cancer Chemother Pharmacol; 2009 Jun 10; 64(1):53-65. PubMed ID: 18931998 [Abstract] [Full Text] [Related]
15. Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells. Issat T, Nowis D, Jakóbisiak M, Golab J. Oncol Rep; 2004 Dec 10; 12(6):1371-5. PubMed ID: 15547765 [Abstract] [Full Text] [Related]
18. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model. Dhamija I, Kumar N, Manjula SN, Parihar V, Setty MM, Pai KS. Exp Toxicol Pathol; 2013 Mar 10; 65(3):235-42. PubMed ID: 21920724 [Abstract] [Full Text] [Related]
19. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR. Clin Cancer Res; 1999 Aug 10; 5(8):2223-9. PubMed ID: 10473109 [Abstract] [Full Text] [Related]